Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
CD44v6: a target for antibody-based cancer therapy
HTML
Details
Locations
Year:
2004
Type:
article
Source:
Cancer Immunology Immunotherapy
DOI:
10.1007/s00262-003-0494-4
Authors:
Karl-Heinz Heider,
Hartmut Kuthan,
Gerd Stehle,
Gerd Munzert
Institutions:
Boehringer Ingelheim (Austria),
Boehringer Ingelheim (Germany)
Language:
English
Topic:
Proteoglycans and glycosaminoglycans research
Subfield:
Cell Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
CD44v6,
CD44 variant isoforms,
alternative splicing,
antibody-based cancer therapy,
tumor invasion,
metastasis,
squamous cell carcinoma,
adenocarcinoma,
epithelial tumors,
tumor-associated antigens,
normal tissue expression
show all 11
SDG:
Good health and well-being
Open Access status:
green
OpenAlex ID:
W2064505748
FWCI:
1.791
Cites:
132
Cited by:
185
Related to:
10